Characterization of endothelial colony-forming cells from peripheral blood samples of adult horses

Margaret M. Salter Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.

Search for other papers by Margaret M. Salter in
Current site
Google Scholar
PubMed
Close
 MS
,
Wen J. Seeto Department of Chemical Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, AL 36849.

Search for other papers by Wen J. Seeto in
Current site
Google Scholar
PubMed
Close
 PhD
,
Blake B. DeWitt Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.

Search for other papers by Blake B. DeWitt in
Current site
Google Scholar
PubMed
Close
 BS
,
Sarah A. Hashimi Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.

Search for other papers by Sarah A. Hashimi in
Current site
Google Scholar
PubMed
Close
 BS
,
Dean D. Schwartz Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.

Search for other papers by Dean D. Schwartz in
Current site
Google Scholar
PubMed
Close
 PhD
,
Elizabeth A. Lipke Department of Chemical Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, AL 36849.

Search for other papers by Elizabeth A. Lipke in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Anne A. Wooldridge Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.

Search for other papers by Anne A. Wooldridge in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

OBJECTIVE To isolate and characterize endothelial colony-forming cells (ECFCs; a subtype of endothelial progenitor cells) from peripheral blood samples of horses.

SAMPLE Jugular venous blood samples from 24 adult horses.

PROCEDURES Blood samples were cultured in endothelial cell growth medium. Isolated ECFCs were characterized by use of functional assays of fluorescence-labeled acetylated low-density lipoprotein (DiI-Ac-LDL) uptake and vascular tubule formation in vitro. Expression of endothelial (CD34, CD105, vascular endothelial growth factor receptor 2, and von Willebrand factor) and hematopoietic (CD14) cell markers was assessed through indirect immunofluorescence assay and flow cytometry. The number of passages before senescence was determined through serial evaluation of DiI-Ac-LDL uptake, vascular tubule formation, and cell doubling rates.

RESULTS Samples from 3 horses produced colonies at 12 ± 2.5 days with characteristic endothelial single layer cobblestone morphology and substantial outgrowth on expansion. Equine ECFCs formed vascular tubules in vitro and had uptake of DiI-Ac-LDL (74.9 ± 14.7% positive cells). Tubule formation and DiI-Ac-LDL uptake diminished by passage 5. Equine ECFCs tested positive for von Willebrand factor, vascular endothelial growth factor receptor 2, CD34, and CD105 with an immunofluorescence assay and for CD14 and CD105 via flow cytometry.

CONCLUSIONS AND CLINICAL RELEVANCE ECFCs can be isolated from peripheral blood of horses and have characteristics similar to those described for other species. These cells may have potential therapeutic use in equine diseases associated with ischemia or delayed vascularization.

Abstract

OBJECTIVE To isolate and characterize endothelial colony-forming cells (ECFCs; a subtype of endothelial progenitor cells) from peripheral blood samples of horses.

SAMPLE Jugular venous blood samples from 24 adult horses.

PROCEDURES Blood samples were cultured in endothelial cell growth medium. Isolated ECFCs were characterized by use of functional assays of fluorescence-labeled acetylated low-density lipoprotein (DiI-Ac-LDL) uptake and vascular tubule formation in vitro. Expression of endothelial (CD34, CD105, vascular endothelial growth factor receptor 2, and von Willebrand factor) and hematopoietic (CD14) cell markers was assessed through indirect immunofluorescence assay and flow cytometry. The number of passages before senescence was determined through serial evaluation of DiI-Ac-LDL uptake, vascular tubule formation, and cell doubling rates.

RESULTS Samples from 3 horses produced colonies at 12 ± 2.5 days with characteristic endothelial single layer cobblestone morphology and substantial outgrowth on expansion. Equine ECFCs formed vascular tubules in vitro and had uptake of DiI-Ac-LDL (74.9 ± 14.7% positive cells). Tubule formation and DiI-Ac-LDL uptake diminished by passage 5. Equine ECFCs tested positive for von Willebrand factor, vascular endothelial growth factor receptor 2, CD34, and CD105 with an immunofluorescence assay and for CD14 and CD105 via flow cytometry.

CONCLUSIONS AND CLINICAL RELEVANCE ECFCs can be isolated from peripheral blood of horses and have characteristics similar to those described for other species. These cells may have potential therapeutic use in equine diseases associated with ischemia or delayed vascularization.

Contributor Notes

Address correspondence to Dr. Wooldridge (aaw0002@auburn.edu).
  • 1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964967.

  • 2. Kovacic JC, Moore J, Herbert A, et al. Endothelial progenitor cells, angioblasts, and angiogenesis—old terms reconsidered from a current perspective. Trends Cardiovasc Med 2008; 18: 4551.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3. Urbich C, Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 2004; 14: 318322.

  • 4. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005; 45: 321325.

  • 5. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625637.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003; 23: 11851189.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 922.

  • 8. Seeto WJ, Tian Y, Lipke EA. Peptide-grafted poly(ethylene glycol) hydrogels support dynamic adhesion of endothelial progenitor cells. Acta Biomater 2013; 9: 82798289.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9. Maeng YS, Choi HJ, Kwon JY, et al. Endothelial progenitor cell homing: prominent role of the IGF2–IGF2R-PLCbeta2 axis. Blood 2009; 113: 233243.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10. Timmermans F, Plum J, Yoder MC, et al. Endothelial progenitor cells: identity defined? J Cell Mol Med 2009; 13: 87102.

  • 11. Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 2011; 50: 266272.

  • 12. Bakogiannis C, Tousoulis D, Androulakis E, et al. Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes. Curr Med Chem 2012; 19: 25972604.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13. Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195199.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14. Petrelli A, Di Fenza R, Carvello M, et al. Strategies to reverse endothelial progenitor cell dysfunction in diabetes. Exp Diabetes Res 2012; 2012: 471823.

    • Search Google Scholar
    • Export Citation
  • 15. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 29812987.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16. Shantsila E, Watson T, Lip GYH. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007; 49: 741752.

  • 17. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 27812786.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 28852890.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Chavakis E, Dimmeler S. Homing of progenitor cells to ischemic tissues. Antioxid Redox Signal 2011; 15: 967980.

  • 20. Nagano M, Yamashita T, Hamada H, et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2007; 110: 151160.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Bai C, Hou L, Zhang M, et al. Characterization of vascular endothelial progenitor cells from chicken bone marrow. BMC Vet Res 2012; 8: 54.

  • 22. Sekiguchi H, Jujo K, Yokoyama A, et al. Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells. PLoS ONE 2011; 6: e28639.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 10351040.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24. Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003; 107: 461468.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Mead LE, Prater D, Yoder MC, et al. Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol 2008;(suppl 6): 2C.1.12C.1.27.

    • Search Google Scholar
    • Export Citation
  • 26. Tsukada S, Kwon SM, Matsuda T, et al. Identification of mouse colony-forming endothelial progenitor cells for postnatal neovascularization: a novel insight highlighted by new mouse colony-forming assay. Stem Cell Res Ther 2013; 4: 20.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Wu H, Riha GM, Yang H, et al. Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells. J Surg Res 2005; 126: 193198.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Godwin EE, Young NJ, Dudhia J, et al. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 2012; 44: 2532.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29. Hofmann NA, Reinisch A, Strunk D. Isolation and large scale expansion of adult human endothelial colony forming progenitor cells. J Vis Exp 2009; 32: 1524.

    • Search Google Scholar
    • Export Citation
  • 30. Reinisch A, Hofmann NA, Obenauf AC, et al. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 2009;113: 67166725.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Rohban R, Reinisch A, Etchart N, et al. Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling. PLoS ONE 2013; 8: e66909.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. MacEachern KE, Smith GL, Nolan AM. Methods for the isolation, culture and characterisation of equine pulmonary artery endothelial cells. Res Vet Sci 1997; 62: 147152.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33. Kang B-J, Lee SH, Kweon O-K, et al. Differentiation of canine adipose tissue–derived mesenchymal stem cells towards endothelial progenitor cells. Am J Vet Res 2014; 75: 685691.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34. Escudero C, González M, Acurio J, et al. The role of placenta in the fetal programming associated to gestational diabetes. In: Sobrevia L, ed. Gestational diabetes: causes, diagnosis and treatment. Rijeka, Croatia: InTech. Available at: www.intechopen.com/books/gestational-diabetes-causes-diagnosis-and-treatment/the-role-of-placenta-in-the-fetal-program-ming-associated-to-gestational-diabetes. Accessed May 15, 2014.

    • Search Google Scholar
    • Export Citation
  • 35. Nishikawa T, Tsuno NH, Tsuchiya T, et al. Sulforaphane stimulates activation of proapoptotic protein bax leading to apoptosis of endothelial progenitor cells. Ann Surg Oncol 2009; 16: 534543.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36. Voyta JC, Via DP, Butterfield CE, et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99: 20342040.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37. Dejana E, Lampugnani MG, Giorgi M, et al. von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism. J Cell Biol 1989; 109: 367375.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38. McEver RP, Cummings RD. Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997; 100: 485491.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39. Holmes K, Roberts OL, Thomas AM, et al. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007; 19: 20032012.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40. Krause DS, Fackler MJ, Civin CI, et al. CD34: structure, biology, and clinical utility. Blood 1996; 87: 113.

  • 41. Duff SE, Li C, Garland JM, et al. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17: 984992.

  • 42. Jersmann HP, Hii CS, Hodge GL, et al. Synthesis and surface expression of CD14 by human endothelial cells. Infect Immun 2001; 69: 479485.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43. Jersmann HPA. Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol Cell Biol 2005; 83: 462467.

  • 44. Kabithe E, Hillegas J, Stokol T, et al. Monoclonal antibodies to equine CD14. Vet Immunol Immunopathol 2010; 138: 149153.

  • 45. Wills TB, Heaney AM, Jane Wardrop K, et al. Immunomagnetic isolation of canine circulating endothelial and endothelial progenitor cells. Vet Clin Pathol 2009; 38: 437442.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46. Hackett CH, Flaminio MJ, Fortier LA. Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow. Stem Cells Dev 2011; 20: 721735.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 34223427.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48. Ferris D, Frisbie D, Kisiday J, et al. In vivo healing of meniscal lacerations using bone marrow-derived mesenchymal stem cells and fibrin glue. Stem Cells Int 1012; 1012: 691605.

    • Search Google Scholar
    • Export Citation
  • 49. Hale BW, Goodrich LR, Frisbie DD, et al. Effect of scaffold dilution on migration of mesenchymal stem cells from fibrin hydrogels. Am J Vet Res 2012; 73: 313318.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50. Watts AE, Ackerman-Yost JC, Nixon AJ. A comparison of three-dimensional culture systems to evaluate in vitro chondrogenesis of equine bone marrow-derived mesenchymal stem cells. Tissue Eng Part A 2013; 19: 22752283.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51. Youngstrom DW, Barrett JG, Jose RR, et al. Functional characterization of detergent-decellularized equine tendon extracellular matrix for tissue engineering applications. PLoS ONE 2013; 8: e64151.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 52. Moon JJ, Saik JE, Poche RA, et al. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010; 31: 38403847.

  • 53. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 15251531.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement